Clofarabine in combination with a standard remission...

Annals of Hematology 2014 / 06 Vol. 93; Iss. 6

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

Willemze, R., Suciu, S., Muus, P., Halkes, C. J. M., Meloni, G., Meert, L., Karrasch, M., Rapion, J., Vignetti, M., Amadori, S., de Witte, T., Marie, J. P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
93
Language:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-014-2056-6
Date:
June, 2014
File:
PDF, 197 KB
english, 2014
Conversion to is in progress
Conversion to is failed